Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
12,439,878
-
Shares change
-
-1,351,635
-
Total reported value, excl. options
-
$34,209,188
-
Value change
-
-$4,757,540
-
Put/Call ratio
-
0%
-
Number of buys
-
15
-
Number of sells
-
-25
-
Price
-
$2.75
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q4 2023
63 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q4 2023.
GeneDx Holdings Corp. - Common Stock (WGS) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,439,878 shares
of 28,736,767 outstanding shares and own 43.29% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3,095,511 shares), Corvex Management LP (2,473,781 shares), GOLDMAN SACHS GROUP INC (1,686,831 shares), Blackstone Inc. (835,062 shares), MORGAN STANLEY (784,127 shares), VANGUARD GROUP INC (678,934 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (643,110 shares), GAGNON SECURITIES LLC (349,278 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (313,659 shares), and BlackRock Inc. (233,972 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.